Induced substrate promiscuity will be important as ADAMTS‐13 variants are developed as potential therapeutic agents against thrombotic thrombocytopenic purpura (TTP) and other cardiovascular diseases. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.